miR-4443 Contained Extracellular Vesicles: A Factor for Endometriosis Progression by PI3K/AKT/ACSS2 Cascade in-vitro
Sifan Ji,Hang Qi,Li Yan,Duo Zhang,Yang Wang,HaLiSai MuDanLiFu,Chuqing He,Wei Xia,Qian Zhu,Yan Liang,Jian Zhang
DOI: https://doi.org/10.2147/ijn.s456594
IF: 7.033
2024-06-20
International Journal of Nanomedicine
Abstract:Sifan Ji, 1, 2, &ast Hang Qi, 1, 2, &ast Li Yan, 1, 2, &ast Duo Zhang, 1, 2 Yang Wang, 1, 2 HaLiSai MuDanLiFu, 1, 2 Chuqing He, 1, 2 Wei Xia, 1, 2 Qian Zhu, 1, 2 Yan Liang, 1, 2 Jian Zhang 1, 2 1 Department of Obstetrics and Gynecology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China; 2 Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jian Zhang, Department of Obstetrics and Gynecology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China, Tel +86 18017316017, Email Introduction: Endometriosis (EM) is an estrogen-dependent benign gynecologic disease affecting approximately 10% of reproductive-age women with a high recurrence rate, but lacks reliable biomarkers. No previous studies have investigated the possible use of extracellular vesicle (EV)-associated micro RNAs (miRNAs) from menstrual blood (MB) as candidate diagnostic or prognostic markers of EM. Methods: Specimens were obtained from endometriosis and non-endometriosis patients at the International Peace Maternity and Child Health Hospital in Shanghai. Microarray was used to screen differentially expressed miRNAs among peritoneal fluid (PF), fallopian tube fluid (FF), and MB. Dual-luciferase reporter gene assay was carried out to verify the relationship between miR-4443 and ACSS2. Cell proliferation and Transwell invasion assays were performed in vitro after intervention on miR-4443 and ACSS2 in hEM15A human endometrial stromal cells and primary human endometrial stromal cells (hESCs). Spearman correlation analysis, receiver operating characteristic (ROC) curve analysis, and survival analysis were applied to clinical data, including severity of symptoms and relapse of EM among EM patients. Results: EV-associated miR-4443 was abundant in MB of endometriosis patients. ACSS2 knockdown and miR-4443 overexpression promoted cell proliferation and migration via the PI3K/AKT pathway. miR-4443 levels in MB-EVs were positively correlated with the degree of dyspareunia (r=0.64; P< 0.0001) and dysmenorrhea (r=0.42; P< 0.01) in the endometriosis group. ROC curve analyses showed an area under the curve (AUC) of 0.741 (95% CI 0.624– 0.858; P< 0.05) for miR-4443 and an AUC of 0.929 (95% CI 0.880– 0.978; P< 0.05) for the combination of miR-4443 and dysmenorrhea. Conclusion: MB-derived EV-associated miR-4443 might participate in endometriosis development, thus providing a new candidate biomarker for the noninvasive prediction of endometriosis recurrence. Keywords: endometriosis, menstrual blood, biomarker, extracellular vesicles, miR-4443 Graphical Endometriosis (EM) is an estrogen-dependent benign gynecologic disease characterized by the growth and invasion of the uterine endometrium outside the uterine cavity. 1 Approximately 10% of reproductive-age women are diagnosed with EM, and 50% of EM patients suffer from chronic pelvic pain (CPP), 1,2 which decreases the quality of life and affects the mental health of patients. 3,4 Laparoscopic surgery remains the gold standard method for diagnosing and treating EM, 5 but laparoscopic surgery is an invasive procedure that requires preparation and may have complications, and it is offered to selected patients. 6 Therefore, finding noninvasive methods for the quick diagnosis and prediction of EM would be important. The pathogenesis of EM and its recurrence are now considered much more complicated than that proposed by the "classic theory" which suggests that menstrual reflux leads to EM since EM occurs in only 10% of women with menstrual reflux. 7,8 Deep EM, stage 3–4 EM, and time interval since surgery are risk factors for EM recurrence, 9 while pregnancy after surgery is a protective factor. 10 Menstrual blood (MB) contains a high concentration of endometrial cells, various cytokines, blood, peritoneal fluid (PF), and fallopian tube fluid (FF), reflecting dysregulation of the pelvic microenvironment of these patients. 11,12 Furthermore, biomarkers in peripheral blood, such as CA125, have been widely applied in clinical work 13–15 but are unreliable as diagnostic biomarkers for EM due to their low sensitivity and specifici -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology